NATIONAL MULTIPLE SCLEROSIS SOCIETY for NATIONAL MULTIPLE SCLEROSIS SOCIETY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CALDER | — |
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Budget/Appropriations BUD
Bill Numbers TBD - Labor, Health and Human Services, Education, Defense, Military Construction and Veterans Affairs, and Food and Drug Administration Appropriations Acts for fiscal year 2021 oDefense Appropriations Act, 2021, support $20 million for the MSRP. oDepartment of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2021: $471 million for the Agency for Healthcare Research and Quality (AHRQ) $8.45 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $10 million for the Lifespan Respite Care Program; Robust funding for Medicare and Medicaid and protection of Medicaids current financing structure; and At least $44.7 billion for the National Institute of Health (NIH), including funds provided to the agency through the 21st Century Cures Act (P.L. 114-255) for targeted initiative; $150 million for the Patient Centered Outcomes Research Institute (PCORI); and At least $13.5 billion for the Social Security Administration oto include report language that directs a review of funding for all of the VA Centers of Excellence and enact a strategy that ensures these important programs are funded in a consistent and transparent manner and that the funding meets the scope and scale of their missions. oSupporting $3.6 billion for the Food and Drug Administration Supporting same funding levels in Senate for these programs. H.R. 6202 Families First Coronavirus Response Act - supplemental appropriations and health provisions related to the COVID-19 pandemic, support passage S.3548 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- supplemental appropriations and health/economic stimulus relating to the COVID-19 pandemic, support passage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Medicare/Medicaid MMM
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CALDER | — |
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Medical/Disease Research/Clinical Labs MED
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Civil Rights/Civil Liberties CIV
N/A
Foreign entity interest: No foreign interests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Transportation TRA
N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH | — |
| JACOB GOODMAN | — |
| LESLIE RITTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.